Your Genetics Determine Whether Sulforaphane Works at All — Here's How to Find Out

Sulforaphane is often marketed as a universal supplement for detox, brain health, and metabolic support. But what nearly all marketing ignores is the dramatic genetic split in how people process sulforaphane, determined by the GSTM1 gene. If you have the GSTM1-null variant (which about half of people do), your body can’t clear out sulforaphane as quickly, leading to three times higher blood levels after taking the same dose compared to someone with an active GSTM1 gene. This means you’re far more likely to experience the touted benefits — while others may notice almost nothing, even at the same dose. This hidden genetic variable is why sulforaphane studies in humans have produced mixed results, while animal and cell studies (which don’t have this genetic split) look much more consistent.

Multiple randomized trials and meta-analyses now confirm that GSTM1-null individuals achieve blood sulforaphane levels three times higher than people with active GSTM1 genes. This translates into measurable health improvements. A meta-analysis of 10 trials found sulforaphane lowered triglycerides by 41 mg/dL in mixed populations - but when studies separated by genetics, GSTM1-null responders saw the biggest drops. Another meta-analysis showed LDL cholesterol reductions of 8 mg/dL, again strongest in genetic responders. Liver health improved too: a 24-week trial found significant ALT reductions, and a 12-week study showed fasting glucose dropped by 0.2 mmol/L in people taking broccoli sprout extract. The key finding: human trials that ignore GSTM1 status mix strong responders with non-responders, making results look weak and inconsistent.

To know if you’re likely to benefit, you need to know your GSTM1 status. Direct-to-consumer genetic testing services can provide this information, often for under $100. If you are GSTM1-null, you are a high responder: studies support daily doses of 30–60 mg sulforaphane (commonly from broccoli sprout extract or fresh sprouts, equivalent to about 20–40 grams fresh sprouts). For GSTM1-positive individuals, the same dose may not deliver much benefit, and higher doses or alternative strategies might be needed — but the evidence for benefit is far weaker in this group. Regardless of genotype, always ensure your sulforaphane supplement includes active myrosinase or take it with a raw cruciferous vegetable to boost conversion from glucoraphanin.

The discovery of the GSTM1 effect reframes sulforaphane from a supplement with average, population-level benefits to a highly personalized tool. It also explains why some people feel noticeable improvements in energy, detox, or metabolic markers — and others report no change. For supplement users, this means you can stop guessing: a simple genetic test tells you if sulforaphane is likely to work for you. For researchers, it highlights the need to stratify trials by GSTM1 status, or risk missing true effects buried in mixed populations.

Sulforaphane works dramatically better for some people than others, and it all comes down to the GSTM1 gene. If you're GSTM1-null (about half the population), you'll get three times higher blood levels and measurable improvements in triglycerides, cholesterol, and liver markers. If you have active GSTM1, the same dose may do very little. A simple genetic test tells you which group you're in, making this a solved problem. For confirmed responders, 30-60 mg daily with myrosinase gives you the best chance of seeing real benefits.